Stay updated on Oral Voxelotor in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.

Latest updates to the Oral Voxelotor in Sickle Cell Disease Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new version of the study page.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a software maintenance update to the site. This change does not modify study data or visible content, but may reflect behind-the-scenes improvements or bug fixes.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a new version of the record. This reflects a maintenance update rather than changes to the study details or outcomes.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer version of the page.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page now includes a recruitment status note indicating recruitment has ended, and adds new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The page revision tag was updated to v3.6.0 and the 'Intervention / Treatment' header formatting was adjusted to 'Intervention/Treatment', replacing the previous v3.5.5 revision indicator.SummaryDifference0.3%

- Check79 days agoChange DetectedThe page version was updated from v3.5.4 to v3.5.5, indicating a minor update to the page. No substantive changes to the study information or layout are indicated by this revision.SummaryDifference0.0%

Stay in the know with updates to Oral Voxelotor in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.